ask="52.79"
ask_size="200"
average_daily_volume="1133570"
bid="51.64"
bid_size="200"
book_value="10.71"
change="+0.33"
change_from_200_day_moving_average="1.56"
change_from_50_day_moving_average="9.18"
change_from_52_week_high="-28.47"
change_From_52_week_low="20.26"
change_in_percent="+0.64%"
close="51.64"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.09"
eps_estimate_next_quarter="-1.30"
eps_estimate_next_year="-4.74"
ex_dividend_date="N/A"
float_shares="71075000"
high="53.94"
high_52_weeks="80.11"
last_trade_date="2/28/2017"
last_trade_price="51.64"
last_trade_size="109478"
last_trade_time="4:00pm"
low="50.74"
low_52_weeks="31.38"
market_capitalization="4.44B"
moving_average_200_day="50.08"
moving_average_50_day="42.46"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="51.50"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="+3.11%"
percent_change_from_50_day_moving_average="+21.61%"
percent_change_from_52_week_high="-35.54%"
percent_change_from_52_week_low="+64.56%"
previous_close="51.31"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.79"
price_per_sales="93.58"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.08"
stock_exchange="NMS"
symbol="ALNY"
volume="1341667"
weeks_range_52="31.38 - 80.11"
